Analysing barriers to service improvement using a multi‐level theory of innovation: the case of glaucoma outpatient clinics [PDF]
Simon Turner +5 more
openalex +1 more source
Background Polymyalgia rheumatica (PMR) is an age‐related inflammatory disease with shoulder‐hip girdle involvement. Magnetic resonance imaging (MRI) reveals extracapsular/entheseal soft tissue involvements in both PMR and spondyloarthritis (SpA) with sacroiliac joint and peri‐entheseal spinal bone marrow oedema (BMO) being characteristic of SpA ...
Kerem Abacar +12 more
wiley +1 more source
Interdisciplinary management of paediatric chronic and complex pain: the experience of a specialised outpatient clinic in Italy. [PDF]
Salerno A +6 more
europepmc +1 more source
Objective To estimate the effect of time from symptom onset to start of biologic treatment on achieving inactive arthritis within six months in a cohort of juvenile idiopathic arthritis (JIA) patients. Methods The international UCAN CAN‐DU study prospectively enrolls JIA patients across Canada and the Netherlands.
Jelleke B. de Jonge +102 more
wiley +1 more source
Correction to: Interdisciplinary management of paediatric chronic and complex pain: the experience of a specialised outpatient clinic in Italy. [PDF]
Salerno A +6 more
europepmc +1 more source
Objective We evaluated serious infection risk in offspring exposed to tumour necrosis factor inhibitors (TNFi) in utero, separated by TNFi timing and placental transfer ability. Methods Using MarketScan (2011‐2021), we identified offspring born to mothers with chronic inflammatory diseases.
Leah K. Flatman +6 more
wiley +1 more source
Translation and cross-cultural adaptation of the Dubowitz Neurological Examination for premature infants in a high-risk outpatient clinic in Brazil. [PDF]
Massarollo ACD +10 more
europepmc +1 more source
Establishing a General Medical Outpatient Clinic for Cancer Survivors in a Public City Hospital Setting [PDF]
Elliott J. Goytia +8 more
openalex +1 more source
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis
Background Transition from long‐term denosumab to PTH‐analogs or romosozumab might expose patients to the risk of the so‐called rebound phenomenon. Adding romosozumab to denosumab might represent an option in patients experiencing a fracture while on denosumab.
Giovanni Adami +10 more
wiley +1 more source

